Neurocrine Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $4.63B
Liabilities Breakdown FY2025
Total Liabilities: $1.38B
Asset Breakdown
Total Assets: $4.63B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $713.0M | 15.4% |
| Accounts Receivable | $686.8M | 14.8% |
| Inventory | $69.0M | 1.5% |
| Property, Plant & Equipment | $89.8M | 1.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.07B | 66.3% |
Liabilities Breakdown
Total Liabilities: $1.38B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.38B | 100.0% |